tiprankstipranks
Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
India Market
JUBLPHARMA
Jubilant Pharmova Limited
RESEARCH TOOLSreports

Jubilant Pharmova Limited (JUBLPHARMA) Ratios

2 Followers

Jubilant Pharmova Limited Ratios

IN:JUBLPHARMA's free cash flow for Q2 2026 was ₹0.32. For the 2026 fiscal year, IN:JUBLPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹0.12. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.66 1.65 2.05 2.12 2.20
Quick Ratio
 1.07 1.13 1.36 1.32 1.40
Cash Ratio
 0.30 0.50 0.50 0.57 0.62
Solvency Ratio
 0.12 0.17 0.06 0.04 0.14
Operating Cash Flow Ratio
 0.18 0.50 0.51 0.37 0.53
Short-Term Operating Cash Flow Coverage
 1.09 3.74 3.93 2.20 1.81
Net Current Asset Value
₹ -34.91B₹ -29.41B₹ -22.51B₹ -20.02B₹ -11.65B
Leverage Ratios
Debt-to-Assets Ratio
 0.21 0.21 0.32 0.33 0.32
Debt-to-Equity Ratio
 0.44 0.44 0.67 0.68 0.60
Debt-to-Capital Ratio
 0.30 0.30 0.40 0.41 0.38
Long-Term Debt-to-Capital Ratio
 0.26 0.26 0.37 0.37 0.32
Financial Leverage Ratio
 2.05 2.04 2.13 2.07 1.88
Debt Service Coverage Ratio
 1.82 1.71 1.34 1.13 1.39
Interest Coverage Ratio
 7.28 9.80 7.58 10.55 17.65
Debt to Market Cap
 0.19 0.17 0.37 0.77 0.47
Interest Debt Per Share
 195.13 187.08 248.12 242.85 209.63
Net Debt to EBITDA
 1.87 1.57 3.42 4.12 2.07
Profitability Margins
Gross Profit Margin
45.14%64.95%64.92%66.86%75.73%
EBIT Margin
10.48%11.11%7.80%5.97%13.70%
EBITDA Margin
15.27%14.48%11.84%10.29%17.39%
Operating Profit Margin
19.13%32.56%30.80%31.60%41.90%
Pretax Profit Margin
8.13%13.55%2.54%0.44%10.28%
Net Profit Margin
5.46%11.60%1.15%-0.97%6.75%
Continuous Operations Profit Margin
5.42%11.56%1.08%-1.03%6.74%
Net Income Per EBT
67.18%85.60%45.22%-219.42%65.66%
EBT Per EBIT
42.51%41.63%8.26%1.40%24.55%
Return on Assets (ROA)
3.20%6.58%0.67%-0.55%4.14%
Return on Equity (ROE)
6.92%13.42%1.42%-1.13%7.78%
Return on Capital Employed (ROCE)
13.25%22.24%21.37%21.15%30.58%
Return on Invested Capital (ROIC)
8.58%18.37%8.84%-47.59%18.87%
Return on Tangible Assets
4.45%9.21%0.96%-0.78%6.07%
Earnings Yield
3.07%5.76%0.85%-1.37%6.70%
Efficiency Ratios
Receivables Turnover
 8.22 8.10 5.36 5.98 5.37
Payables Turnover
 4.34 2.52 2.75 2.53 2.62
Inventory Turnover
 3.54 2.25 1.80 1.46 1.16
Fixed Asset Turnover
 1.34 1.40 1.82 1.87 2.20
Asset Turnover
 0.59 0.57 0.58 0.56 0.61
Working Capital Turnover Ratio
 11.55 4.26 3.37 3.22 3.21
Cash Conversion Cycle
 63.53 62.94 137.58 166.30 244.23
Days of Sales Outstanding
 44.40 45.03 68.12 61.06 68.02
Days of Inventory Outstanding
 103.22 162.54 202.39 249.25 315.47
Days of Payables Outstanding
 84.09 144.64 132.93 144.01 139.26
Operating Cycle
 147.62 207.58 270.51 310.31 383.49
Cash Flow Ratios
Operating Cash Flow Per Share
 23.30 67.50 61.23 41.51 52.61
Free Cash Flow Per Share
 -23.40 -2.74 4.64 -9.66 14.92
CapEx Per Share
 46.70 70.24 56.59 51.18 37.69
Free Cash Flow to Operating Cash Flow
 -1.00 -0.04 0.08 -0.23 0.28
Dividend Paid and CapEx Coverage Ratio
 0.45 0.90 0.99 0.74 1.23
Capital Expenditure Coverage Ratio
 0.50 0.96 1.08 0.81 1.40
Operating Cash Flow Coverage Ratio
 0.13 0.39 0.27 0.18 0.26
Operating Cash Flow to Sales Ratio
 0.05 0.15 0.14 0.11 0.14
Free Cash Flow Yield
-2.63%-0.30%0.81%-3.47%3.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 32.61 17.35 118.23 -72.75 14.93
Price-to-Sales (P/S) Ratio
 1.78 2.01 1.36 0.71 1.01
Price-to-Book (P/B) Ratio
 2.14 2.33 1.68 0.82 1.16
Price-to-Free Cash Flow (P/FCF) Ratio
 -38.06 -334.81 123.85 -28.86 26.01
Price-to-Operating Cash Flow Ratio
 38.24 13.58 9.38 6.72 7.38
Price-to-Earnings Growth (PEG) Ratio
 -3.46 0.02 -0.52 0.63 -0.54
Price-to-Fair Value
 2.14 2.33 1.68 0.82 1.16
Enterprise Value Multiple
 13.54 15.47 14.91 10.99 7.87
Enterprise Value
 163.67B 162.07B 118.26B 71.01B 83.91B
EV to EBITDA
 13.54 15.47 14.91 10.99 7.87
EV to Sales
 2.07 2.24 1.76 1.13 1.37
EV to Free Cash Flow
 -44.15 -372.57 160.67 -46.17 35.32
EV to Operating Cash Flow
 44.36 15.12 12.18 10.75 10.02
Tangible Book Value Per Share
 174.69 163.76 120.64 126.43 134.88
Shareholders’ Equity Per Share
 416.14 393.82 342.53 339.26 334.07
Tax and Other Ratios
Effective Tax Rate
 0.33 0.15 0.57 3.33 0.34
Revenue Per Share
 499.91 455.50 422.52 394.71 385.05
Net Income Per Share
 27.32 52.85 4.86 -3.83 26.00
Tax Burden
 0.67 0.86 0.45 -2.19 0.66
Interest Burden
 0.78 1.22 0.33 0.07 0.75
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.26 0.32 0.33 0.35 0.33
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 0.64 1.28 12.60 23.78 1.33
Currency in INR